Skip to main content

Table 1 Data from screening and recruitment paperwork completed by pharmacists

From: A non-randomised pilot study of the Solutions for Medication Adherence Problems (S-MAP) intervention in community pharmacies to support older adults adhere to multiple medications

  NI London Total
Initial screening proceduresa  
 Number of screening forms completed 74 24 98
 Number of patients who completed the screening questionnaire (%) 52 (70.3) 22 (91.7) 74 (75.5)
 Non-adherence rateb, % (number of eligible non-adherent patients) 46.2 (24); missing = 2 81.8 (18); missing = 0 56.8 (42); missing = 2
 Recruitment ratec, % (number recruited) 62.5 (15) 77.8 (14) 69.0 (29)
Modified screening proceduresd  
 Number of screening forms completed 30 12 42
 Non-adherence ratee, % (number of eligible non-adherent patients) 73.3 (22) 83.3 (10) 76.2 (32)
 Recruitment ratec, % (number recruited) 95.5 (21) 100 (10) 96.9 (31)
 Total number of screened patients (%) 104 (74.3) 36 (25.7) 140
Characteristics of recruited patients    
 Total number of patients recruited (%) 36 (60.0%) 24 (40.0%) 60
 Mean age (± SD; range) 70.1 (± 8.5; 50-85); missing = 0 68.3 (± 8.8; 50-84); missing = 2 69.5 (± 8.6; 50-85); missing = 2
 Female, n (%) 23 (63.9) 14 (58.3) 37 (61.7)
 Median number of prescribed medications (IQR; range) 7 (6-8; 4-13); missing = 1 8 (5-9; 3-15); missing = 1 7 (5.8-8.3; 3-15); missing = 2
 Median number of prescribed regular medications (IQR; range) 6 (5-7; 3-12); missing = 1 6 (5-7; 3-9); missing = 1 6 (5-7; 3-12); missing = 2
 Median number of prescribed non-regularf medications (IQR; range) 0 (0-1; 0-4); missing = 1 1 (0-3; 0-7); missing = 1 1 (0-2; 0-7); missing = 2
  1. aIncluded a screening questionnaire (Lu item and MARS-5) to assess adherence. Patients aged 65+ were eligible to take part
  2. bNumber of eligible non-adherent patients from the total number who completed adherence screening questionnaire
  3. cNumber of patients recruited from the total number of eligible non-adherent patients
  4. dAdherence assessment completed using the PMR or via general discussions with the patients. Age limit lowered to 50+ years
  5. eNumber of eligible non-adherent patients from the total number of patients screened
  6. fIncludes medications used on a short-term basis or generally for symptomatic (when required) use